Furthermore, clinical studies have demonstrated that the levels of circulating FGF21 increased significantly in patients with early diabetic nephropathy and hypertensive nephropathy (Ong et al. 2015; Huang et al. 2017; Lei et al. 2020). This evidence concerns the gene FGF21 and diabetic kidney disease.